Biospyder Technologies, Inc.
Last verified 2026-05-17. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.6Mattributed |
|---|---|
| Latest round | grant, $2.6M, 2023-09-01attributed |
| Founded | unknown |
| Headquarters | Carlsbad, California, USA |
| Industry | bio |
| Stage | unknown |
| Website | biospyder.com |
BioSpyder runs the TempO-Seq targeted-sequencing platform, profiling hundreds to thousands of genes across many samples by ligating template-dependent oligo barcodes. It is used by toxicology, oncology, and pharma teams running compound screening and translational studies. Multiplexes up to 6,144 samples per run with under one hour of hands-on time, no full DNA conversion.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-09-01 | grant | $2.6M | undisclosed |
Detected tech stack
Typekit, Adobe Fonts, Afterpay, Sentry, Spin.js, Squarespace, Squarespace Commerce, Stimulus, web-vitals, moment 0, @sentry/browser
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.6M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.6M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | biospyder.com, read 2026-05-17 |
| Description | self-reported | biospyder.com, read 2026-05-17 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.